NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) breached their fiduciary duties to shareholders.

Pursuant to a state securities lawsuit, Ampio Pharmaceuticals insiders caused the company to make false and/or misleading statements and/or failed to disclose the following: (i) inflated the company’s true ability to successfully file a BLA for Ampion; (ii) the results of the AP-013 study and the timing of unblinding the data from the AP-013 study were overstated; and (iii) that as a result of the foregoing, statements about the Company’s business, operations and prospects were materially misleading and/or lacked a reasonable basis.

If you own AMPE please contact Justin Kuehn, Esq. by email at [email protected] or by calling (212) 709-8245. You will not incur any costs. Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers. please visit http://www.moorekuehn.com/practice/new-york-shareholder-derivative-litigation/

attorney advertising. Previous results do not guarantee similar results.

Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8^th floor
New York, New York 10005
[email protected]
(212) 709-8245